In MASLD cases with increased FGF21 expression TSC2 was markedly down‐regulated, and the negative correlation between FGF21 and TSC1 or TSC2 was significant. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatotic liver disease.